Skip to main content

Table 4 List of differentially methylated sites (DMS), differentially methylated regions (DMRs) and genes content in the four comparisons

From: Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Comparison DMS DMR Genes
WT1 and WT2 versus FXS1 7343 40 32
WT1 and WT2 versus FXS2 33,950 365 300
FXS1 UT versus FXS1 T1 (n = 2) 1706 0 0
FXS2 UT versus FXS2 T1 (n = 2) 528 0 0